Most drugmakers have so far ignored looming FTC deadline to withdraw or amend wayward patents

Only one company has responded to an FTC demand for several drugmakers to delist dozens of patents that were improperly or inaccurately listed in a government registry.

Dec 7, 2023 - 18:00
Most drugmakers have so far ignored looming FTC deadline to withdraw or amend wayward patents

With 10 days to go, only one company has responded to a demand by the U.S. Federal Trade Commission for several brand-name drugmakers to delist dozens of patents that were improperly or inaccurately listed in a government registry, according to a source familiar with the matter.

As a result, the agency is readying plans to file lawsuits against the other companies, some of which are among the biggest drugmakers in the world, such as AbbVie, AstraZeneca, and GSK. The FTC notified the companies on Nov. 7 that they must withdraw or amend the patent listings, or an individual must certify under penalty of perjury that the listings comply with federal law and regulations.

Read the rest…

What's Your Reaction?

like

dislike

love

funny

angry

sad

wow